Perimeter Medical Imaging AI Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Full Article
Perimeter Medical Imaging AI Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Perimeter Medical Imaging AI, Inc. reported significant growth in its second quarter 2024 financial results, with revenues increasing by 83% compared to the previous year. The company achieved six new placements of its FDA-cleared Perimeter S-Series OCT system, surpassing the total placements from all of 2023. Additionally, advancements in the development of the next-generation Perimeter B-Series OCT system are underway, with expectations for FDA submission in 2025.

The ongoing pivotal clinical trial for the B-Series OCT system is on track for completion by Q3-2024, ahead of schedule. A recent study highlighted the effectiveness of the S-Series OCT in reducing reoperation rates for breast-conserving surgeries, showcasing its potential impact on patient outcomes. The introduction of the ImgClear AI image enhancement algorithm is expected to further improve imaging quality and efficiency.

• Perimeter's revenues grew 83% year-over-year in Q2-2024.

• The ImgClear AI algorithm enhances imaging quality and reduces scan time.

Key AI Terms Mentioned in this Article

Optical Coherence Tomography (OCT)

The Perimeter S-Series OCT system utilizes this technology to provide real-time visualization during cancer surgeries.

Artificial Intelligence (AI)

Perimeter's B-Series OCT system incorporates AI to enhance imaging capabilities and improve surgical outcomes.

ImgClear

The implementation of ImgClear is expected to significantly increase the signal-to-noise ratio and reduce scan times.

Companies Mentioned in this Article

Perimeter Medical Imaging AI

The company is known for its FDA-cleared Perimeter S-Series OCT system, which aids in real-time tissue visualization.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics